Citations

Showing 10 of 108083 citations.

Coxiella burnetii Multilevel Disk Space Infection, Epidural Abscess, and Vertebral Osteomyelitis Secondary to Contiguous Spread From Infected Abdominal Aortic Aneurysm or Graft: Report of 4 Cases Acquired in the US and Review of the Literature
Virk, Abinash , Mahmood, Maryam , Kalra, Manju , Bower, Thomas C., Osmon, Douglas R. , Berbari, Elie F. , Raoult, Didier , Mahmood, Maryam

Mayo Clinic

Open Forum Infectious Diseases | October 17, 2017 | Volume: 4 | Issue: 4 | Pages: No page available

10.1093/ofid/ofx192 | PMID 30581879 Get It

Abstract Background Chronic Coxiella burnetii infections such as vertebral osteomyelitis caused by contiguous spread from an infected abdominal aortic graft or aneurysm have been rarely reported and are associated with significant morbidity and mortality. Methods We present the first four reported US acquired cases of Coxiella burnetii vertebral osteomyelitis caused by contiguous spread from an infected abdominal aortic graft or aneurysm. Results Presenting symptoms included progressive back pain, malaise, and weight loss with recent or remote animal exposure. Typical imaging findings demonstrated a peri-aortic collection with extension to the paraspinal muscles and vertebrae. Antibiotic regimens included doxycycline with either hydroxychloroquine or a quinolone for at least 2 years or as chronic suppression. Conclusions C. burnetii vertebral osteomyelitis is rare and can occur by contiguous spread from an abdominal aneurysm or vascular graft infection. It should be suspected in patients where pre-antibiotic cultures are negative with animal/farming exposure.
Association of urinary citrate excretion, pH, and net gastrointestinal alkali absorption with diet, diuretic use, and blood glucose concentration
Perinpam, Majuran, Smith, Jennifer A. , Kardia, Sharon L. R., Turner, Stephen T. , Smith, Jennifer A , Ware, Erin Bakshis , Lieske, John C.

Mayo Clinic

Physiological Reports | October 17, 2017 | Volume: 5 | Issue: 19 | Pages: e13411

10.14814/phy2.13411 | PMID 29038354 Get It

Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence
Kottke, Tim , Evgin, Laura , Shim, Kevin G. , Rommelfanger, Diana M., Boisgerault, Nicolas , Zaidi, Shane, Díaz, Rosa María, Thompson, Jill , Ilett, Elizabeth J. , Selby, Peter J. , Pandha, Hardev , Harrington, Kevin J. , Melcher, Alan , Vile, Richard G. , Rommelfanger, Diana, Ilett, Elizabeth J , Melcher, Alan A , Shim, Kevin G , Harrington, Kevin , Coffey, Matt C.

Mayo Clinic

Cancer Immunology Research | October 17, 2017 | Volume: 5 | Issue: 11 | Pages: 1029-1045

10.1158/2326-6066.cir-17-0175 | PMID 29038298 Get It

AbstractUnderstanding how incompletely cleared primary tumors transition from minimal residual disease (MRD) into treatment-resistant, immune-invisible recurrences has major clinical significance. We show here that this transition is mediated through the subversion of two key elements of innate immunosurveillance. In the first, the role of TNFα changes from an antitumor effector against primary tumors into a growth promoter for MRD. Second, whereas primary tumors induced a natural killer (NK)–mediated cytokine response characterized by low IL6 and elevated IFNγ, PD-L1hi MRD cells promoted the secretion of IL6 but minimal IFNγ, inhibiting both NK-cell and T-cell surveillance. Tumor recurrence was promoted by trauma- or infection-like stimuli inducing VEGF and TNFα, which stimulated the growth of MRD tumors. Finally, therapies that blocked PD-1, TNFα, or NK cells delayed or prevented recurrence. These data show how innate immunosurveillance mechanisms, which control infection and growth of primary tumors, are exploited by recurrent, competent tumors and identify therapeutic targets in patients with MRD known to be at high risk of relapse. Cancer Immunol Res; 5(11); 1029–45. ©2017 AACR.
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Jun, Tomi , Yang, Ju Dong , Chen, Vincent , Nguyen, Pauline, Giama, Nasra H., Huang, Chung‐Feng , Hsing, Ann W. , Chuang, Wan‐Long , Roberts, Lewis R. , Yu, Ming‐Lung , Nguyen, Mindie H. , Nguyen, Mindie H , Roberts, Lewis R , Chen, V L , Yu, M-L , Yeh, Ming-Lun , Yang, Ju Dong , Dai, Chia-Yen , Huang, Jee‐Fu

Mayo Clinic

Liver International | October 16, 2017 | Volume: 38 | Issue: 5 | Pages: 895-902

10.1111/liv.13613 | PMID 29045023 Get It

AbstractBackground & AimsAlthough hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major risk factors for hepatocellular carcinoma (HCC), non‐viral causes of HCC, particularly non‐alcoholic fatty liver disease (NAFLD), are becoming increasingly prevalent. The aim of this study was to compare the clinical characteristics and survival of cryptogenic and viral HCC.MethodsWe conducted a retrospective cohort study involving 3878 consecutive HCC patients seen at two tertiary centres in the United States and one in Taiwan from 2004 to 2014. We compared the clinical characteristics, treatment and survival of patients by underlying aetiology: cryptogenic (n = 696), HBV (n = 1304) or HCV (n = 1878).ResultsCirrhosis was present in 66.8% of the cryptogenic HCC patients, compared with 74.7% of HBV‐related HCC (HBV‐HCC) (P = .001) and 85.9% of HCV‐HCC (P < .001). Compared to viral HCC, cryptogenic HCC patients presented with larger tumours and at later stages of disease. Five‐year overall survival was 16.3% among cryptogenic HCC patients compared with 31.9% among HBV‐HCC patients and 27.7% among HCV‐HCC patients (P < .001 for both by the log‐rank test). HCC aetiology was not an independent predictor of survival, though ethnicity, cirrhosis status, meeting Milan criteria and treatment allocation were.ConclusionsCompared with viral HCC patients, those with cryptogenic HCC had lower prevalence of cirrhosis, were diagnosed with larger tumours at more advanced stages of disease, and had poorer overall survival. Additional efforts are needed to identify patients at risk of cryptogenic HCC and to identify cryptogenic HCC at earlier stages of disease.
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Gall, Émilie Cornec-Le , Torres, Vicente E. , Cornec-Le Gall, Emilie, Torres, Vicente E , Harris, Peter C. , Cornec-Le Gall, Emilie

Mayo Clinic

Journal of the American Society of Nephrology | October 16, 2017 | Volume: 29 | Issue: 1 | Pages: 13-23

10.1681/asn.2017050483 | PMID 29038287 Get It

Data indicate significant phenotypic and genotypic overlap, plus a common pathogenesis, between two groups of inherited disorders, autosomal dominant polycystic kidney diseases (ADPKD), a significant cause of ESRD, and autosomal dominant polycystic liver diseases (ADPLD), which result in significant PLD with minimal PKD. Eight genes have been associated with ADPKD ( PKD1 and PKD2 ), ADPLD ( PRKCSH , SEC63 , LRP5 , ALG8 , and SEC61B ), or both ( GANAB ). Although genetics is only infrequently used for diagnosing these diseases and prognosing the associated outcomes, its value is beginning to be appreciated, and the genomics revolution promises more reliable and less expensive molecular diagnostic tools for these diseases. We therefore propose categorization of patients with a phenotypic and genotypic descriptor that will clarify etiology, provide prognostic information, and better describe atypical cases. In genetically defined cases, the designation would include the disease and gene names, with allelic (truncating/nontruncating) information included for PKD1 . Recent data have shown that biallelic disease including at least one weak ADPKD allele is a significant cause of symptomatic, very early onset ADPKD. Including a genic (and allelic) descriptor with the disease name will provide outcome clues, guide treatment, and aid prevalence estimates.
Effect of nephrectomy for retroperitoneal sarcoma on post‐operative renal function
Kim, Daniel B. , Gray, Richard J. , Li, Zhuo , Wasif, Nabil , Kim, Daniel B. , Bagaria, Sanjay P.

Mayo Clinic

Journal of Surgical Oncology | October 16, 2017 | Volume: 117 | Issue: 3 | Pages: 425-429

10.1002/jso.24875 | PMID 29044533 Get It

Background and ObjectivesSurgical resection of retroperitoneal sarcomas (RPS) often involves removal of the ipsilateral kidney. We evaluated the long‐term post‐operative renal function in patients who underwent a nephrectomy as part of their en‐bloc resection of RPS.MethodsRetrospective review of an institutional database identified RPS patients who underwent nephrectomy for curative intent from 1990 to 2014. The primary outcome measured was chronic kidney disease (CKD) calculated by the glomerular filtration rate (GFR).ResultsOf the 47 patients in our study, 19 (40%), 18 (38%), and 10 (21%) patients had a preoperative CKD stage 1, 2, and 3, respectively. The GFR decreased by an average of 33.4 mL/min/1.73 m2 with 66% of patients demonstrating mild progression of their renal impairment. Only three (6%) patients progressed to CKD stage 4 or 5, one of which required life‐long dialysis.ConclusionNephrectomy as part of an en‐bloc resection is associated with a decrease in GFR that is not clinically significant. Fear of kidney failure should not prevent a surgeon from performing a nephrectomy in the treatment of RPS.
Provider views on the management of Ewing sarcoma of the spine and pelvis
Zhu, Chong , Olson, Kristofor A. , Geller, David S. , Görlick, Richard , Laack, Nadia N. , Randall, RL, Laack, Nadia N Issa , Gorlick, Richard , Roth, Michael , Gill, Jonathan Benjamin

Mayo Clinic

Journal of Surgical Oncology | October 16, 2017 | Volume: 117 | Issue: 3 | Pages: 417-424

10.1002/jso.24860 | PMID 29044582 Get It

BackgroundCurative therapy for ES requires both chemotherapy and local control of primary tumor. There is no universally accepted standard approach to local control modalities. This survey was conducted to determine practice patterns and factors influencing the choice to offer various local control modalities to patients with ES of the spine and pelvis.MethodsThe survey consisted of four scenarios involving a 15‐year‐old girl who presented with Ewing sarcoma of thoracic vertebra, sacrum, iliac wing, and acetabulum with or without neurologic compromise. The questionnaire was sent to oncologists, orthopedic surgeons, and radiation oncologists, asking their recommendations for local control modality.ResultsAmong 94 respondents, radiotherapy was most frequently chosen for sacral tumors (68.1%) and T10 vertebral tumors (46.2%) whereas surgery was preferred for iliac wing pelvic tumors (45.7%) and acetabular tumors (43.6%). Orthopedic surgeons were significantly more likely to offer surgery than radiation oncologists (OR 3.07, 95%CI 1.37‐6.88, P = 0.007). Providers outside North America were more likely to offer combined surgery plus radiotherapy (OR 10.58, 95%CI 5.41‐20.70, P < 0.001).ConclusionConsiderable heterogeneity exists in local control modalities for Ewing sarcoma of the spine and pelvis. Specialty and location of practice may influence treatment recommendations.
TIEG and estrogen modulate SOST expression in the murine skeleton
Subramaniam, Malayannan , Pitel, Kevin S., Bruinsma, Elizabeth S. , Hawse, John R. , Monroe, David G. , Hawse, John R

Mayo Clinic

Journal of Cellular Physiology | October 16, 2017 | Volume: 233 | Issue: 4 | Pages: 3540-3551

10.1002/jcp.26211 | PMID 29044507 Get It

TIEG knockout (KO) mice exhibit a female‐specific osteopenic phenotype and altered expression of TIEG in humans is associated with osteoporosis. Gene expression profiling studies identified sclerostin as one of the most highly up‐regulated transcripts in the long bones of TIEG KO mice relative to WT littermates suggesting that TIEG may regulate SOST expression. TIEG was shown to substantially suppress SOST promoter activity and the regulatory elements through which TIEG functions were identified using promoter deletion and chromatin immunoprecipitation assays. Knockdown of TIEG in IDG‐SW3 osteocyte cells using shRNA and CRISPR‐Cas9 technology resulted in increased SOST expression and delayed mineralization, mimicking the results obtained from TIEG KO mouse bones. Given that TIEG is an estrogen regulated gene, and as changes in the hormonal milieu affect SOST expression, we performed ovariectomy (OVX) and estrogen replacement therapy (ERT) studies in WT and TIEG KO mice followed by miRNA and mRNA sequencing of cortical and trabecular compartments of femurs. SOST expression levels were considerably higher in cortical bone compared to trabecular bone. In cortical bone, SOST expression was increased following OVX only in WT mice and was suppressed following ERT in both genotypes. In contrast, SOST expression in trabecular bone was decreased following OVX and significantly increased following ERT. Interestingly, a number of miRNAs that are predicted to target sclerostin exhibited inverse expression levels in response to OVX and ERT. These data implicate important roles for TIEG and estrogen‐regulated miRNAs in modulating SOST expression in bone.
Clinical Reasoning: A 46-year-old man with persistent hiccups, cognitive dysfunction, and imbalance
Lamb, Christopher J. , López‐Chiriboga, A. Sebastian , Mendez, Julio, Robinson, Maisha T. , Sotello Aviles, David A , Mendez, Julio C, Lamb, Christopher J , Sotello, David

Mayo Clinic

Neurology | October 16, 2017 | Volume: 89 | Issue: 16 | Pages: No page available

10.1212/wnl.0000000000004523 | PMID 29038139 Get It

Teaching Neuro Images : Spontaneous involution of symptomatic delayed tumefactive cyst following radiosurgery for AVM
Aiello, Giovanni, Snyder, Kendall, Brinjikji, Waleed , Lanzino, Giuseppe

Mayo Clinic

Neurology | October 16, 2017 | Volume: 89 | Issue: 16 | Pages: No page available

10.1212/wnl.0000000000004520 | PMID 29038141 Get It